Sarma; Keshab
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sarma; Keshab.The latest application filed is for "processes for preparing antiviral compounds".
Company Profile
3.20.27
- Sarma; Keshab - Sunnyvale CA
- SARMA; Keshab - Sunnycale US
- Sarma; Keshab - Kinnelon NJ
Patent Activity
| Patent | Date |
|---|---|
| Processes for preparing antiviral compounds Grant 11,192,875 - Allan , et al. December 7, 2 | 2021-12-07 |
| Processes For Preparing Antiviral Compounds App 20200392100 - Allan; Kevin M. ; et al. | 2020-12-17 |
| Processes for preparing antiviral compounds Grant 10,584,109 - Allan , et al. | 2020-03-10 |
| Processes For Preparing Antiviral Compounds App 20190263771 - Allan; Kevin M. ; et al. | 2019-08-29 |
| Processes for preparing antiviral compounds Grant 9,890,134 - Allan , et al. February 13, 2 | 2018-02-13 |
| Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide Grant 9,828,340 - Fishlock , et al. November 28, 2 | 2017-11-28 |
| Processes For Preparing Antiviral Compounds App 20170283390 - Allan; Kevin M. ; et al. | 2017-10-05 |
| Processes For Preparing Ask1 Inhibitors App 20170233350 - Brown; Brandon Heath ; et al. | 2017-08-17 |
| Processes for preparing antiviral compounds Grant 9,670,187 - Allan , et al. June 6, 2 | 2017-06-06 |
| Processes For Preparing Fused Heterocyclic Ion Channel Modulators App 20160332976 - Chiu; Anna ; et al. | 2016-11-17 |
| Processes For Preparing Fused Heterocyclic Ion Channel Modulators App 20160332977 - Chiu; Anna ; et al. | 2016-11-17 |
| Processes for preparing ASK1 inhibitors App 20160244430 - Brown; Brandon Heath ; et al. | 2016-08-25 |
| Asymmetric Synthesis Of A Substituted Pyrrolidine-2-carboxamide App 20160002158 - FISHLOCK; Daniel ; et al. | 2016-01-07 |
| Processes For Preparing Antiviral Compounds App 20150361073 - Allan; Kevin M. ; et al. | 2015-12-17 |
| Processes For Preparing Fused Heterocyclic Ion Channel Modulators App 20150225384 - Chiu; Anna ; et al. | 2015-08-13 |
| Preparation of nucleosides ribofuranosyl pyrimidines Grant 8,912,321 - Axt , et al. December 16, 2 | 2014-12-16 |
| Inhibitors of Bruton's tyrosine kinase Grant 8,299,077 - Berthel , et al. October 30, 2 | 2012-10-30 |
| Antiviral nucleosides Grant 8,236,779 - Ma , et al. August 7, 2 | 2012-08-07 |
| Antiviral Nucleosides App 20110150829 - Ma; Han ; et al. | 2011-06-23 |
| Inhibitors of Bruton's Tyrosine Kinase App 20100222325 - Berthel; Steven ; et al. | 2010-09-02 |
| Antiviral nucleosides Grant 7,754,699 - Chun , et al. July 13, 2 | 2010-07-13 |
| Process for preparing triazolones Grant 7,745,634 - Arzeno , et al. June 29, 2 | 2010-06-29 |
| Preparation Of Nucleosides Ribofuranosyl Pyrimidines App 20100056770 - Axt; Steven D. ; et al. | 2010-03-04 |
| Antiviral nucleosides Grant 7,645,745 - Sarma January 12, 2 | 2010-01-12 |
| Process for the preparation of 3-amino-pentan-1,5-diol Grant 7,635,784 - Cleary , et al. December 22, 2 | 2009-12-22 |
| Process for the preparation of 4'-azido cytidine derivatives Grant 7,632,940 - Harrington , et al. December 15, 2 | 2009-12-15 |
| Methods for synthesis of 3-amino-1-arylpropyl indoles Grant 7,598,399 - Connolly , et al. October 6, 2 | 2009-10-06 |
| Process for preparing triazolones App 20090012304 - Arzeno; Humberto Bartolome ; et al. | 2009-01-08 |
| Novel Process For The Preparation Of 3-amino-pentan-1,5-diol App 20080312467 - Cleary; Thomas ; et al. | 2008-12-18 |
| Selective O-acylation of nucleosides Grant 7,439,344 - Sarma October 21, 2 | 2008-10-21 |
| Process for the preparation of 4'-Azido cytidine derivatives App 20080161550 - Harrington; Peter John ; et al. | 2008-07-03 |
| Preparation of nucleosides ribofuranosyl pyrimidines App 20080139802 - Axt; Steven D. ; et al. | 2008-06-12 |
| Anti-viral nucleosides Grant 7,378,402 - Martin , et al. May 27, 2 | 2008-05-27 |
| Antiviral nucleosides App 20070232562 - Sarma; Keshab | 2007-10-04 |
| Antiviral nucleosides App 20070197463 - Chun; Byoung-Kwon ; et al. | 2007-08-23 |
| Methods for synthesis of 3-amino-1-arylpropyl indoles App 20070135647 - Connolly; Terrence Joseph ; et al. | 2007-06-14 |
| Selective O-acylation of nucleosides App 20070066815 - Sarma; Keshab | 2007-03-22 |
| Anti-viral nucleosides App 20060040890 - Martin; Joseph Armstrong ; et al. | 2006-02-23 |
| Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytos ine hemisulfate as useful as an antiviral agent Grant 6,864,244 - Connolly , et al. March 8, 2 | 2005-03-08 |
| Processes for preparing 4'-azido-nucleoside derivatives App 20050038240 - Connolly, Terrence Joseph ; et al. | 2005-02-17 |
| Antiviral nucleoside derivatives Grant 6,846,810 - Martin , et al. January 25, 2 | 2005-01-25 |
| Novel anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxyme- thyl)-1(R)-cyclopentyl]cytosine hemisulfate as useful as an antiviral agent App 20040162265 - Connolly, Terrence Joseph ; et al. | 2004-08-19 |
| Antiviral nucleoside derivatives App 20040121969 - Hendricks, Robert Than ; et al. | 2004-06-24 |
| Antiviral nucleoside derivatives App 20040121980 - Martin, Joseph Armstrong ; et al. | 2004-06-24 |
| Matrix metalloprotease inhibitors Grant 5,932,595 - Bender , et al. August 3, 1 | 1999-08-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 